Foster Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$389K Buy
+2,053
New +$386K 0.01% 208
2026
Q1
Sell
-1,536
Closed -$282K 289
2025
Q4
$282K Buy
1,536
+209
+16% +$36.7K 0.01% 224
2025
Q3
$204K Buy
+1,327
New +$201K 0.01% 260

Other funds holding AZN

Foster Group's AZN Position: Q2 2026 in Review

Foster Group opened a new position in AstraZeneca (AZN) in Q2 2026: 2,053 shares worth $389K. The stake represents 0.01% of the portfolio and ranks #208 among its holdings. This is a return to the name: Foster Group previously reported a position in AZN as recently as Q4 2025.

Foster Group first reported a position in AZN in Q3 2025 and has held it in 3 quarters since. 233 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Foster Group held 2,053 shares of AstraZeneca worth $389K as of Q2 2026.
  • AstraZeneca was a new Foster Group position in Q2 2026.
  • AstraZeneca made up 0.01% of Foster Group's portfolio in Q2 2026, its #208 holding.
  • Foster Group first reported a position in AstraZeneca in Q3 2025 and has held it in 3 quarters since.
  • 233 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.